Autoantibodies to mucocutaneous antigens

Autoantibodies

Volumn , Issue , 2007, Pages 765-780

  Grando, Sergei A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84864856268     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044452763-9/50099-8     Document Type: Chapter

References (65)

1. Amagai M, Klaus-Kovtun V, Stanley JR Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991, 67:869-877.
2. Barlow Y, Wray D Ultrastructural alterations associated with in vivo and in vitro bound pemphigus antibodies in cultured oral epithelial cells. J Oral Pathol Med 1991, 20:241-244.
3. Shimizu A, Ishiko A, Ota T, Tsunoda K, Amagai M, Nishikawa T IgG binds to desmoglein 3 in desmosomes and causes a desmosomal split without keratin retraction in a pemphigus mouse model. J Invest Dermatol 2004, 122:1145-1153.
4. Nguyen VT, Ndoye A, Shultz LD, Pittelkow MR, Grando SA Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. J Clin Invest 2000, 106:1467-1479.
5. Grando SA New approaches to the treatment of pemphigus. J Invest Dermatol Symp Proc 2004, 9:84-91.
6. Muramatsu T, Shirai T, Iida T, Yamashina Y, Sakamoto K Antigen specificities of antibasement membrane zone antibodies: Immunofluorescence and Western immunoblotting studies. Arch Dermatol Res 1988, 280:411-415.
7. Jamora MJ, Jiao D, Bystryn JC Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris. J Am Acad Dermatol 2003, 48:976-977.
8. Donetti E, Bedoni M, Boschini E, Dellavia C, Barajon I, Gagliano N Desmocollin 1 and desmoglein 1 expression in human epidermis and keratinizing oral mucosa: A comparative immunohistochemical and molecular study. Arch Dermatol Res 2005, 297:31-38.
9. Kljuic A, Bazzi H, Sundberg JP, et al. Desmoglein 4 in hair follicle differentiation epidermal adhesion.Evidence from inherited hypotrichosis and acquired pemphigus vulgaris. Cell 2003, 113:249-260.
10. Nagasaka T, Nishifuji K, Ota T, Whittock NV, Amagai M Defining the pathogenic involvement of desmoglein 4 in pemphigus and staphylococcal scalded skin syndrome. J Clin Invest 2004, 114:1484-1492.
11. Nguyen VT, Lee TX, Ndoye A, et al. The pathophysiological significance of non-desmoglein targets of pemphigus autoimmunity: Pemphigus vulgaris and foliaceus patients develop antibodies against keratinocyte cholinergic receptors. Arch Dermatol 1998, 134:971-980.
12. Nguyen VT, Ndoye A, Grando SA Pemphigus vulgaris antibody identifies pemphaxin-a novel keratinocyte annexin-like molecule binding acetylcholine. J Biol Chem 2000, 275:29466-29476.
13. Joly P, Gilbert D, Thomine E, et al. Identification of a new antibody population directed against a desmosomal plaque antigen in pemphigus vulgaris and pemphigus foliaceus. J Invest Dermatol 1997, 108:469-475.
14. Fiebiger E, Hammerschmid F, Stingl G, Maurer D Anti-FcεRIα autoantibodies in autoimmunemediated disorders: Identification of a structure-function relationship. J Clin Invest 1998, 101:243-251.
15. Pitoia F, Moncet D, Glorio R, et al. Prevalence of thyroid autoimmunity in patients with pemphigus vulgaris. Medicina (B Aires) 2005, 65:307-310.
16. Hashimoto T, Ebihara T, Nishikawa T Studies of autoantigens recognized by IgA anti-keratinocyte cell surface antibodies. J Dermatol Sci 1996, 12:10-17.
17. Kiss M, Husz S, Janossy T, et al. Experimental bullous pemphigoid generated in mice with an antigenic epitope of the human hemidesmosomal protein BP230. J Autoimmun 2005, 24:1-10.
18. Liu Z, Diaz LA, Troy JL, et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 1993, 92:2480-2488.
19. Stahle-Backdahl M, Inoue M, Guidice GJ, Parks WC 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J Clin Invest 1994, 93:2022-2030.
20. Kiss M, Perenyi A, Marczinovits I, et al. Autoantibodies to human alpha6 integrin in patients with bullous pemphigoid. Ann NY Acad Sci 2005, 1051:104-110.
21. Presslauer S, Hinterhuber G, Cauza K, et al. RasGAP-like protein IQGAP1 is expressed by human keratinocytes and recognized by autoantibodies in association with bullous skin disease. J Invest Dermatol 2003, 120:365-371.
22. Wozniak K, Kazama T, Kowalewski C A practical technique for differentiation of subepidermal bullous diseases: Localization of in vivo-bound IgG by laser scanning confocal microscopy. Arch Dermatol 2003, 139:1007-1011.
23. Oyama N, Setterfield JF, Powell AM, et al. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: The pathogenic relevance to HLA class II alleles and disease severity. Br J Dermatol 2006, 154:90-98.
24. Bhol KC, Goss L, Kumari S, Colon JE, Ahmed AR Autoantibodies to human alpha6 integrin in patients with oral pemphigoid. J Dent Res 2001, 80:1711-1715.
25. Lazarova Z, Yee C, Darling T, Briggaman RA, Yancey KB Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J Clin Invest 1996, 98:1509-1518.
26. Powell AM, Sakuma-Oyama Y, Oyama N, et al. Usefulness of BP180 NC16a enzyme-linked immunosorbent assay in the serodiagnosis of pemphigoid gestationis and in differentiating between pemphigoid gestationis and pruritic urticarial papules and plaques of pregnancy. Arch Dermatol 2005, 141:705-710.
27. Shimanovich I, Skrobek C, Rose C, et al. Pemphigoid gestationis with predominant involvement of oral mucous membranes and IgA autoantibodies targeting the C-terminus of BP180. J Am Acad Dermatol 2002, 47:780-784.
28. Kromminga A, Sitaru C, Meyer J, et al. Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain. J Dermatol Sci 2002, 28:68-75.
29. Yoon KH, Kim SC, Kang DS, Lee IJ Lichen planus pemphigoides with circulating autoantibodies against 200 and 180 kDa epidermal antigens. Eur J Dermatol 2000, 10:212-214.
30. Allen J, Wojnarowska F Linear IgA disease: The IgA and IgG response to dermal antigens demonstrates a chiefly IgA response to LAD285 and a dermal 180-kDa protein. Br J Dermatol 2003, 149:1055-1058.
31. Zone JJ, Egan CA, Taylor TB, Meyer LJ IgA autoimmune disorders: Development of a passive transfer mouse model. J Investig Dermatol Symp Proc 2004, 9:47-51.
32. Foedinger D, Anhalt GJ, Boecskoer B, Elbe A, Wolff K, Rappersberger K Autoantibodies to desmoplakin I and II in patients with erythema multiforme. J Exp Med 1995, 181:169-179.
33. Foedinger D, Elbe-Burger A, Sterniczky B, et al. Erythema multiforme associated human autoantibodies against desmoplakin I and II: Biochemical characterization and passive transfer studies into newborn mice. J Invest Dermatol 1998, 111:503-510.
34. Hinterhuber G, Binder M, Marquardt Y, et al. Enzyme-linked immunosorbent assay for detection of peptide-specific human antidesmoplakin autoantibodies. Br J Dermatol 2005, 153:413-416.
35. Nguyen VT, Ndoye A, Bassler KD, et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: A reappraisal of paraneoplastic pemphigus. Arch Dermatol 2001, 137:193-206.
36. Anhalt GJ, Kim SC, Stanley JR, et al. Paraneoplastic pemphigus: An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990, 323:1729-1735.
37. Preisz K, Horvath A, Sardy M, et al. Exacerbation of paraneoplastic pemphigus by cyclophosphamide treatment: Detection of novel autoantigens and bronchial autoantibodies. Br J Dermatol 2004, 150:1018-1024.
38. Zillikens D, Brocker EB Paraneoplastic pemphigus: Induction of autoantibodies against structural proteins in the skin. Hautarzt 1994, 45:827-833.
39. Ongenae K, Van Geel N, Naeyaert JM Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 2003, 16:90-100.
40. Norris DA, Kissinger RM, Naughton GM, Bystryn JC Evidence for immunologic mechanisms in human vitiligo: Patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. J Invest Dermatol 1988, 90:783-789.
41. Cui J, Arita Y, Bystryn JC Characterization of vitiligo antigens. Pigment Cell Res 1995, 8:53-59.
42. Song YH, Connor E, Li Y, Zorovich B, Balducci P, Maclaren N The role of tyrosinase in autoimmune vitiligo. Lancet 1994, 344:1049-1052.
43. Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: A sensitive and quantitative radioimmunoassay (RIA). Clin Exp Immunol 1998, 114:333-338.
44. Kemp EH, Waterman EA, Hawes BE, et al. The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo. J Clin Invest 2002, 109:923-930.
45. Hedstrand H, Ekwall O, Olsson MJ, et al. The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I. J Biol Chem 2001, 276:35390-35395.
46. Woodley DT, Burgeson RE, Lunstrum G, Bruckner-Tuderman L, Reese MJ, Briggaman RA Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest 1988, 81:683-687.
47. Lapiere JC, Woodley DT, Parente MG, et al. Epitope mapping of type VII collagen.Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 1993, 92:1831-1839.
48. Shimanovich I, Mihai S, Oostingh GJ, et al. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J Pathol 2004, 204:519-527.
49. Woodley DT, Chang C, Saadat P, Ram R, Liu Z, Chen M Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol 2005, 124:958-964.
50. Sitaru C, Zillikens D Mechanisms of blister induction by autoantibodies. Exp Dermatol 2005, 14:861-875.
51. Vodegel RM, Kiss M, Cjm De Jong M, et al. The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease. Eur J Dermatol 1998, 8:83-85.
52. Wakelin SH, Bhogal B, Black MM, et al. Epidermolysis bullosa acquisita associated with epidermalbinding circulating antibodies. Br J Dermatol 1997, 136:604-609.
53. Jonkman MF, Schuur J, Dijk F, et al. Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin alpha3. Arch Dermatol 2000, 136:227-231.
54. Gammon WR, Briggaman RA Epidermolysis bullosa acquisita bullous systemic lupus erythematosus.Diseases of autoimmunity to type VII collagen. Dermatol Clin 1993, 11:535-547.
55. Yell JA, Allen J, Wojnarowska F, Kirtschig G, Burge SM Bullous systemic lupus erythematosus: revised criteria for diagnosis. Br J Dermatol 1995, 132:921-928.
56. Chan LS, Lapiere JC, Chen M, et al. Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. Arch Dermatol 1999, 135:569-573.
57. McCord ML, Hall RP IgA antibodies against reticulin and endomysium in the serum and gastrointestinal secretions of patients with dermatitis herpetiformis. Dermatology 1994, 189(Suppl 1):60-63.
58. Karpati S, Stolz W, Meurer M, Krieg T, Braun-Falco O Extracellular binding sites of IgA antijejunal antibodies on normal small bowel detected by indirect immunoelectronmicroscopy. J Invest Dermatol 1991, 96:228-233.
59. Menzel EJ, Pehamberger H, Holubar K Demonstration of antibodies to wheat gliadin in dermatitis herpetiformis using 14C-radioimmunoassay. Clin Immunol Immunopathol 1978, 10:193-201.
60. Marietta E, Black K, Camilleri M, et al. A new model for dermatitis herpetiformis that uses HLADQ8 transgenic NOD mice. J Clin Invest 2004, 114:1090-1097.
61. Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002, 195:747-757.
62. Karpati S Dermatitis herpetiformis: Close to unravelling a disease. J Dermatol Sci 2004, 34:83-90.
63. Dahlback K, Sakai L IgA immunoreactive deposits collocal with fibrillin immunoreactive fibers in dermatitis herpetiformis skin. Acta Derm. Venereol. 1990, 70:194-198.
64. Chan LS, Fine JD, Briggaman RA, et al. Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease. J Invest Dermatol 1993, 101:262-267.
65. Grando SA Autoimmunity to keratinocyte acetylcholine receptors in pemphigus. Dermatology 2000, 201.